332 related articles for article (PubMed ID: 27102208)
1. Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade.
Suen H; Brown R; Yang S; Weatherburn C; Ho PJ; Woodland N; Nassif N; Barbaro P; Bryant C; Hart D; Gibson J; Joshua D
Leukemia; 2016 Aug; 30(8):1716-24. PubMed ID: 27102208
[TBL] [Abstract][Full Text] [Related]
2. T cells in multiple myeloma display features of exhaustion and senescence at the tumor site.
Zelle-Rieser C; Thangavadivel S; Biedermann R; Brunner A; Stoitzner P; Willenbacher E; Greil R; Jöhrer K
J Hematol Oncol; 2016 Nov; 9(1):116. PubMed ID: 27809856
[TBL] [Abstract][Full Text] [Related]
3. Inappropriate Expression of PD-1 and CTLA-4 Checkpoints in Myeloma Patients Is More Pronounced at Diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors.
Kulikowska de Nałęcz A; Ciszak L; Usnarska-Zubkiewicz L; Pawlak E; Frydecka I; Szmyrka M; Kosmaczewska A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982802
[TBL] [Abstract][Full Text] [Related]
4. The T Cell in Myeloma.
Joshua D; Suen H; Brown R; Bryant C; Ho PJ; Hart D; Gibson J
Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):537-542. PubMed ID: 27601001
[TBL] [Abstract][Full Text] [Related]
5. Clonal cytotoxic T cells in myeloma.
Sze DM; Brown RD; Yuen E; Gibson J; Ho J; Raitakari M; Basten A; Joshua DE; Fazekas de St Groth B
Leuk Lymphoma; 2003 Oct; 44(10):1667-74. PubMed ID: 14692517
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine and viral correlates of premature immunosenescence.
Bauer ME; Wieck A; Petersen LE; Baptista TS
Ann N Y Acad Sci; 2015 Sep; 1351():11-21. PubMed ID: 25943573
[TBL] [Abstract][Full Text] [Related]
7. Senescence markers: Predictive for response to checkpoint inhibitors.
Moreira A; Gross S; Kirchberger MC; Erdmann M; Schuler G; Heinzerling L
Int J Cancer; 2019 Mar; 144(5):1147-1150. PubMed ID: 30151962
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic significance of programmed death protein 1 and programmed death ligand-1, and cytotoxic T lymphocyte-associated molecule-4 in hepatocellular carcinoma.
Chang H; Jung W; Kim A; Kim HK; Kim WB; Kim JH; Kim BH
APMIS; 2017 Aug; 125(8):690-698. PubMed ID: 28493410
[TBL] [Abstract][Full Text] [Related]
9. Methods for Characterization of Senescent Circulating and Tumor-Infiltrating T-Cells: An Overview from Multicolor Flow Cytometry to Single-Cell RNA Sequencing.
Franzin R; Stasi A; Castellano G; Gesualdo L
Methods Mol Biol; 2021; 2325():79-95. PubMed ID: 34053052
[TBL] [Abstract][Full Text] [Related]
10. Senescent phenotypes and telomere lengths of peripheral blood T-cells mobilized by acute exercise in humans.
Simpson RJ; Cosgrove C; Chee MM; McFarlin BK; Bartlett DB; Spielmann G; O'Connor DP; Pircher H; Shiels PG
Exerc Immunol Rev; 2010; 16():40-55. PubMed ID: 20839490
[TBL] [Abstract][Full Text] [Related]
11. Individual myeloma-specific T-cell clones eliminate tumour cells and correlate with clinical outcomes in patients with multiple myeloma.
Michalek J; Ocadlikova D; Matejkova E; Foltankova V; Dudová S; Slaby O; Horvath R; Pour L; Hajek R
Br J Haematol; 2010 Mar; 148(6):859-67. PubMed ID: 20067568
[TBL] [Abstract][Full Text] [Related]
12. Immunosenescence: a key player in cancer development.
Lian J; Yue Y; Yu W; Zhang Y
J Hematol Oncol; 2020 Nov; 13(1):151. PubMed ID: 33168037
[TBL] [Abstract][Full Text] [Related]
13. Reversing T-cell Dysfunction and Exhaustion in Cancer.
Zarour HM
Clin Cancer Res; 2016 Apr; 22(8):1856-64. PubMed ID: 27084739
[TBL] [Abstract][Full Text] [Related]
14. The Role of T Cell Senescence in Neurological Diseases and Its Regulation by Cellular Metabolism.
Fessler J; Angiari S
Front Immunol; 2021; 12():706434. PubMed ID: 34335619
[TBL] [Abstract][Full Text] [Related]
15. Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients.
Barathan M; Mohamed R; Vadivelu J; Chang LY; Saeidi A; Yong YK; Ravishankar Ram M; Gopal K; Velu V; Larsson M; Shankar EM
Eur J Clin Invest; 2016 Feb; 46(2):170-80. PubMed ID: 26681320
[TBL] [Abstract][Full Text] [Related]
16. Gene expression changes in long-term culture of T-cell clones: genomic effects of chronic antigenic stress in aging and immunosenescence.
Mazzatti DJ; White A; Forsey RJ; Powell JR; Pawelec G
Aging Cell; 2007 Apr; 6(2):155-63. PubMed ID: 17286612
[TBL] [Abstract][Full Text] [Related]
17. T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy.
Chung DJ; Pronschinske KB; Shyer JA; Sharma S; Leung S; Curran SA; Lesokhin AM; Devlin SM; Giralt SA; Young JW
Cancer Immunol Res; 2016 Jan; 4(1):61-71. PubMed ID: 26464015
[TBL] [Abstract][Full Text] [Related]
18. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance.
Botta C; Perez C; Larrayoz M; Puig N; Cedena MT; Termini R; Goicoechea I; Rodriguez S; Zabaleta A; Lopez A; Sarvide S; Blanco L; Papetti DM; Nobile MS; Besozzi D; Gentile M; Correale P; Siragusa S; Oriol A; González-Garcia ME; Sureda A; de Arriba F; Rios Tamayo R; Moraleda JM; Gironella M; Hernandez MT; Bargay J; Palomera L; Pérez-Montaña A; Goldschmidt H; Avet-Loiseau H; Roccaro A; Orfao A; Martinez-Lopez J; Rosiñol L; Lahuerta JJ; Blade J; Mateos MV; San-Miguel JF; Martinez Climent JA; Paiva B; ;
Nat Commun; 2023 Sep; 14(1):5825. PubMed ID: 37730678
[TBL] [Abstract][Full Text] [Related]
19. Immune checkpoint blockade immunotherapy to activate anti-tumour T-cell immunity.
Ramsay AG
Br J Haematol; 2013 Aug; 162(3):313-25. PubMed ID: 23691926
[TBL] [Abstract][Full Text] [Related]
20. Expansion of a clonal CD8+CD57+ large granular lymphocyte population after autologous stem cell transplant in multiple myeloma.
Wolniak KL; Goolsby CL; Chen YH; Chenn A; Singhal S; JayeshMehta ; Peterson LA
Am J Clin Pathol; 2013 Feb; 139(2):231-41. PubMed ID: 23355208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
